Massive vaccine deal makes Intercell's day
One of the most significant deals to take place in the vaccine
industry in the last ten years was signed late last night between
vaccine heavyweight Novartis and biotech firm Intercell.
Encorium, Amarex, Paragon Biomedical, Pacific Biometrics and Parexel – Clinical contract news
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community this past week, involving Encorium,
Amarex, Paragon Biomedical, Pacific Biometrics and Parexel.
Indian CRO eyes US or EU buyout
India's Reliance Life Sciences (RLS) is planning an acquisition in
Europe or in the US joining the slow infiltration of Indian firms
cementing themselves in Western markets.
Pfizer's first day in Nigerian court in child death dispute
Pfizer has had its first day in a Nigerian court in a legal dispute
over its alleged involvement in the death of Nigerian children
during a clinical trial 11 years ago.
Indian clinical research industry shaping up
India's clinical research industry took on more shape this week
with the launch of the Indian version of the Association of
Clinical Research Professionals (ACRP) and the government's
proposed new regulations on clinical...
ICON eyeing Europe for observational research
ICON Clinical Research is stepping up its efforts to bring
observational clinical research to European customers.
INC Research says new process hastens trial start dates
INC Research said it is now able to bring the start date for its
clinical trials forward by two weeks following the implementation
of a company-wide process improvement strategy.
Parexel talks Tegenero and Phase I future
Parexel talks to Outsourcing-Pharma about Phase I trials, touching
on trends and growth opportunities, future plans for India and
lessons learned from Tegenero.
Finnish CRO dives into metabolomics sea
Finnish CRO Technical Research Center (VTT) has spun-off Zora
Biosciences, which becomes the only company in the Nordic region to
provide metabolomics services to pharma companies - a market with
Russians left in the dark despite lifted export ban
Despite a lift of the ban on biological sample transportation out
of Russia, the country's clinical research industry is still in the
dark on the new rules to control export of such materials.
Parexel opens first Indian operation
US contract research organisation (CRO) Parexel has just announced
the establishment of its first operation in India.
EU and US agencies bolster bonds
European and US regulatory bodies have revamped their relationship
to ease administrative burdens and improve communication, as well
as implementing new measures directed specifically at paediatric
Diamyd tries to salvage something from clinical wreck
Diamyd Medical will continue with a clinical trial of its gene
therapy designed to protect insulin-producing cells in diabetes
patients, despite major errors invalidating the study.
Synexus 'confident' despite profit drop
UK-based Synexus was optimistic last week when it announced its
preliminary financial results for the year, despite a plummeting
Nicholas Piramal opens second research site
Nicholas Piramal India (NPIL) has opened its second clinical
research facility and is eyeing the growing area of